ALK c.1553C>T ;(p.A518V)

Variant ID: 2-29541264-G-A

NM_004304.4(ALK):c.1553C>T;(p.A518V)

This variant was identified in 1 publication

View GRCh38 version.



Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP

Publications:

GLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancer.

Oncology Letters
Dong, Zhouhuan Z; Wang, Yun Y; Ding, Vivianne V; Yan, Xiang X; Lv, Yali Y; Zhong, Mei M; Zhu, Fengwei F; Zhao, Po P; He, Charlotte C; Ding, Feng F; Shi, Huaiyin H
Publication Date: 2020-10

Variant appearance in text: ALK: A518V
PubMed Link: 32863909
Variant Present in the following documents:
  • Main text
View BVdb publication page